FR15C0005I2 - Composes derives de benzothiazole, compositions et utilisations - Google Patents

Composes derives de benzothiazole, compositions et utilisations

Info

Publication number: FR15C0005I2
Authority: FR; France
Prior art keywords: benzothiazole; compositions; derived compounds; derived; compounds
Prior art date: 2003-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR15C0005C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Pittsburgh

Original Assignee

University of Pittsburgh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-14

Filing date

2015-01-21

Publication date

2015-07-24

2003-03-14 Priority claimed from US10/388,173 external-priority patent/US7270800B2/en

2003-08-22 Priority claimed from US10/645,847 external-priority patent/US20050043523A1/en

2004-03-15 Priority claimed from PCT/US2004/007797 external-priority patent/WO2004083195A1/fr

2015-01-21 Application filed by University of Pittsburgh filed Critical University of Pittsburgh

2015-07-24 Application granted granted Critical

2015-07-24 Publication of FR15C0005I2 publication Critical patent/FR15C0005I2/fr

Status Active legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Cell Biology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Neurosurgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Magnetic Resonance Imaging Apparatus (AREA)
Thiazole And Isothizaole Compounds (AREA)

FR15C0005C 2003-03-14 2015-01-21 Composes derives de benzothiazole, compositions et utilisations Active FR15C0005I2 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/388,173 US7270800B2 (en)	2000-08-24	2003-03-14	Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US10/645,847 US20050043523A1 (en)	2003-08-22	2003-08-22	Benzothiazole derivative compounds, compositions and uses
PCT/US2004/007797 WO2004083195A1 (fr)	2003-03-14	2004-03-15	Composes derives de benzothiazole, compositions et utilisations

Publications (1)

Publication Number	Publication Date
FR15C0005I2 true FR15C0005I2 (fr)	2015-07-24

Family

ID=35057877

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR15C0005C Active FR15C0005I2 (fr)	2003-03-14	2015-01-21	Composes derives de benzothiazole, compositions et utilisations

Country Status (17)

Country	Link
EP (1)	EP1611115B1 (fr)
JP (1)	JP4875487B2 (fr)
CN (2)	CN102532055B (fr)
AU (2)	AU2004221897B2 (fr)
BE (1)	BE2015C005I2 (fr)
BR (1)	BRPI0408274B8 (fr)
CY (2)	CY1113334T1 (fr)
DK (1)	DK1611115T3 (fr)
ES (1)	ES2393921T3 (fr)
FR (1)	FR15C0005I2 (fr)
HK (1)	HK1086270A1 (fr)
HU (1)	HUS1500006I1 (fr)
NO (3)	NO330861B1 (fr)
PL (1)	PL1611115T3 (fr)
PT (1)	PT1611115E (fr)
RU (1)	RU2440995C2 (fr)
SI (1)	SI1611115T1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU230375B1 (hu) *	2000-08-24	2016-03-29	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Tioflavin-származékok és alkalmazásuk az Alzheimer-kór diagnózisában és kezelésében
US7270800B2 (en)	2000-08-24	2007-09-18	University Of Pittsburgh	Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US20050261365A1 (en) *	2004-05-20	2005-11-24	The Scripps Research Institute	Transthyretin stabilization
GB0516564D0 (en) *	2005-08-12	2005-09-21	Ge Healthcare Ltd	Fluorination process
CA2675228A1 (fr) *	2007-01-30	2008-07-07	Ge Healthcare Limited	Instruments d'aide au diagnostic de maladies neurodegeneratives
CN101293878B (zh) *	2007-04-25	2010-12-15	中国科学院上海应用物理研究所	苯并噻唑苯胺类化合物及其制备方法和应用
CA2731738A1 (fr) *	2008-07-24	2010-01-28	Siemens Medical Solutions Usa, Inc.	Agents d'imagerie utiles pour identifier une pathologie
EP2338059B1 (fr) *	2008-09-23	2015-04-08	WisTa Laboratories Ltd.	Ligands pour molécules de la protéine tau agglomérées
KR101770532B1 (ko)	2013-09-26	2017-08-22	에프. 호프만-라 로슈 아게	이미징 수단으로서의 이미다조[1,2-a]피리딘-7-아민
JP6260967B2 (ja) *	2013-11-06	2018-01-17	国立大学法人京都大学	放射性ヨウ素標識化合物、及び、これを含む放射性医薬
CN103613589B (zh) *	2013-11-29	2016-03-30	江苏华益科技有限公司	一种用于神经退行性疾病领域的新型pet显像剂前体及标准品的合成方法
JP2017528520A (ja) *	2014-08-29	2017-09-28	シーエイチディーアイファウンデーション，インコーポレーテッド	ハンチントンタンパク質のイメージング用プローブ
CN109400615B (zh) *	2017-08-18	2021-07-16	上海交通大学医学院附属新华医院	一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
GR1009516B (el) *	2018-03-22	2019-05-02	Εκεφε Δημοκριτος	Τρικαρβονυλο-συμπλοκα μεταλλων μεταπτωσεως με βενζο-ετεροκυκλικο παραγωγο του κυκλοπενταδιενυλικου ανιοντος με υψηλη διαπερατοτητα του αιματοεγκεφαλικου φραγμου για εφαρμογες στη διαγνωση και θεραπεια νοσων του κνς

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ID22275A (id) *	1996-11-22	1999-09-23	Elan Pharm Inc	Komposisi farmasi yang terdiri dari derivat asam amino n-(aril atau heteroaril) dan metode untuk menghambat pelepasan b-amiloid peptida dan atau sintesisnya dengan menggunakan senyawa tersebut
GB9919673D0 (en) *	1999-08-20	1999-10-20	Cancer Res Campaign Tech	2-Arlybenzazole compounds
HU230375B1 (hu) *	2000-08-24	2016-03-29	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Tioflavin-származékok és alkalmazásuk az Alzheimer-kór diagnózisában és kezelésében
JP2004524289A (ja) *	2000-12-22	2004-08-12	アストラゼネカ・アクチエボラーグ	治療化合物
EP1381604B1 (fr) *	2001-04-23	2006-12-27	The Trustees Of The University Of Pennsylvania	Inhibiteurs d'agregation de plaque amyloide et agents d'imagerie diagnostique
GB0229686D0 (en) *	2002-12-20	2003-01-29	Amersham Plc	Solid-phase fluorination of benzothiazoles

2004
- 2004-03-15 PT PT47207881T patent/PT1611115E/pt unknown
- 2004-03-15 CN CN201110437182.5A patent/CN102532055B/zh not_active Expired - Lifetime
- 2004-03-15 BR BRPI0408274A patent/BRPI0408274B8/pt active IP Right Grant
- 2004-03-15 SI SI200431952T patent/SI1611115T1/sl unknown
- 2004-03-15 PL PL04720788T patent/PL1611115T3/pl unknown
- 2004-03-15 AU AU2004221897A patent/AU2004221897B2/en not_active Expired
- 2004-03-15 EP EP04720788A patent/EP1611115B1/fr not_active Expired - Lifetime
- 2004-03-15 RU RU2005131872/04A patent/RU2440995C2/ru not_active Application Discontinuation
- 2004-03-15 DK DK04720788.1T patent/DK1611115T3/da active
- 2004-03-15 ES ES04720788T patent/ES2393921T3/es not_active Expired - Lifetime
- 2004-03-15 CN CNA2004800125035A patent/CN1784392A/zh active Pending
- 2004-03-15 JP JP2006507179A patent/JP4875487B2/ja not_active Expired - Lifetime
2005
- 2005-10-11 NO NO20054674A patent/NO330861B1/no active Protection Beyond IP Right Term
2006
- 2006-07-04 HK HK06107502.0A patent/HK1086270A1/xx not_active IP Right Cessation
2011
- 2011-02-16 AU AU2011200667A patent/AU2011200667B2/en not_active Expired
- 2011-07-06 NO NO20110980A patent/NO20110980L/no not_active Application Discontinuation
2012
- 2012-11-16 CY CY20121101106T patent/CY1113334T1/el unknown
2015
- 2015-01-21 FR FR15C0005C patent/FR15C0005I2/fr active Active
- 2015-01-27 BE BE2015C005C patent/BE2015C005I2/fr unknown
- 2015-02-18 NO NO2015005C patent/NO2015005I1/no not_active IP Right Cessation
- 2015-02-18 HU HUS1500006C patent/HUS1500006I1/hu unknown
- 2015-03-04 CY CY2015007C patent/CY2015007I1/el unknown

Also Published As

Publication number	Publication date
AU2004221897A2 (en)	2004-09-30
RU2440995C2 (ru)	2012-01-27
AU2004221897A9 (en)	2009-08-20
NO330861B1 (no)	2011-08-01
CN102532055B (zh)	2016-05-11
CN1784392A (zh)	2006-06-07
NO20110980L (no)	2005-12-13
AU2004221897B2 (en)	2010-11-18
JP2006522104A (ja)	2006-09-28
JP4875487B2 (ja)	2012-02-15
CN102532055A (zh)	2012-07-04
AU2011200667A1 (en)	2011-03-10
RU2005131872A (ru)	2006-02-27
BRPI0408274B1 (pt)	2019-02-26
PL1611115T3 (pl)	2013-01-31
BRPI0408274B8 (pt)	2021-05-25
SI1611115T1 (sl)	2012-12-31
NO20054674D0 (no)	2005-10-11
BE2015C005I2 (fr)	2023-03-07
NO2015005I2 (no)	2015-02-18
EP1611115A1 (fr)	2006-01-04
PT1611115E (pt)	2012-12-07
AU2004221897A1 (en)	2004-09-30
HK1086270A1 (en)	2006-09-15
NO20054674L (no)	2005-12-13
BRPI0408274A (pt)	2006-03-21
EP1611115B1 (fr)	2012-08-22
CY1113334T1 (el)	2015-12-09
AU2011200667B2 (en)	2011-12-22
NO2015005I1 (no)	2015-03-02
ES2393921T3 (es)	2013-01-02
HUS1500006I1 (hu)	2015-02-18
DK1611115T3 (da)	2012-11-26
CY2015007I1 (el)	2015-12-09

Publication	Publication Date	Title
FR15C0005I2 (fr)	2015-07-24	Composes derives de benzothiazole, compositions et utilisations
FR14C0066I2 (fr)	2015-05-22	2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
DK1684731T3 (da)	2012-10-15	Filmdannende stivelsesholdig sammensætning
ATE478069T1 (de)	2010-09-15	3,4-dihydro-2h-benzoä1,4üoxazin- und 3,4-dihydro- 2h-benzoä1,4üthiazin-verbindungen als alpha2c- adrenorezeptor-antagonisten
MX266708B (es)	2009-06-24	Formulaciones de microparticulas de pantoprazol.
DE10393374D2 (de)	2005-09-01	Zusammensetzung
DK1613694T3 (da)	2010-10-11	Polyalkenaminer med forbedrede anvendelsesegenskaber
ATE417648T1 (de)	2009-01-15	Stifte zusammensetzungen
NO20042756L (no)	2004-12-17	Francisturbin.
DE60305332D1 (de)	2006-06-22	IMIDAZOi1,2-AöPYRIDINE
ATE518848T1 (de)	2011-08-15	3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate
EP1848438A4 (fr)	2010-09-01	Compositions de diaminophenothiazine et utilisations associees
DK1492934T3 (da)	2010-10-04	Dørenhed
BR0300119B1 (pt)	2013-04-09	composiÇço aquosa.
SE0500163L (sv)	2005-01-24	Sammansättning
FR2875805B1 (fr)	2006-12-29	Composes derives de n-(benzyl) phenylacetamide substitues, preparation et utilisations
DE60331383D1 (de)	2010-04-08	Dämpfer
FI20020313A (fi)	2003-08-16	Uudet tärkkelyskoostumukset
EP1737458A4 (fr)	2010-08-04	Derives de r(-)-11-hydroxyaporphines et utilisations de ces derives
DE602004025335D1 (de)	2010-03-18	Dämpfer
ES1051506Y (es)	2002-12-01	Juguete de composicion.
EP1561467A4 (fr)	2008-06-25	Composition dermo-reparatrice
EP1658301A4 (fr)	2009-12-09	Composes n-desmethyl-11-desoxyerythromycine-n-substitues
FR2861290B1 (fr)	2006-02-10	Composition cosmetique thermogonflante.
FR2864956B1 (fr)	2006-04-28	Compose derive de 1,3-diphenylprop-2-en-1-one, preparation et utilisations